Bill Text: OH SB271 | 2013-2014 | 130th General Assembly | Introduced

---

Bill Title: To require a retail terminal distributor of dangerous drugs to verify the prospective purchaser's identity when dispensing a controlled substance or tramadol.

Sponsorship: Partisan Bill (Republican 2)

Status: (Introduced - Dead) 2014-02-04 - To Commerce & Labor [SB271 Detail]

Download: Ohio-2013-SB271-Introduced.html

---

As Introduced

130th General Assembly Regular Session 2013-2014

S. B. No. 271

Senator Jones 

Cosponsor: Senator Seitz 

---

A BILL

To enact section 4729.553 of the Revised Code to

1

require a retail terminal distributor of dangerous

2

drugs to verify the prospective purchaser's

3

identity when dispensing a controlled substance or

4

tramadol.

5

BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF OHIO:

Section 1. That section 4729.553 of the Revised Code be	6
enacted to read as follows:	7

Sec. 4729.553. (A) As used in this section, "purchaser" means	8
an individual engaged in the act of purchasing a dangerous drug	9
from a licensed terminal distributor of dangerous drugs and	10
includes either the individual for whom the prescription for the	11
drug is issued or an individual acting on behalf of the individual	12
for whom the prescription is issued.	13

(B) Except as provided in division (E) of this section, prior	14
to selling at retail a controlled substance or drug containing	15
tramadol, a licensed terminal distributor of dangerous drugs shall	16
do both of the following:	17

(1) Verify the identity of the prospective purchaser of the	18
drug against either of the following:	19

(a) A valid identification card bearing a photograph of the	20
prospective purchaser, issued by a state or federal agency;	21

(b) A form of identification authorized by the state board of	22
pharmacy in rules adopted under division (D) of this section.	23

(2) Record all of the following:

24

(a) The name of the individual purchasing the drug;

25

(b) The type of identification presented;

26

(c) The unique identification number printed by the issuing	27
agency on the identification, if the number exists.	28

(C) The terminal distributor shall retain the information	29
required by division (B) of this section for three years. The	30
information is subject to inspection for official purposes by law	31
enforcement officers and employees of the board.	32

(D) The board may adopt rules authorizing for purposes of	33
this section the use of identification other than that described	34
in division (B)(1)(a) of this section. The rules shall be adopted	35
in accordance with Chapter 119. of the Revised Code.	36

(E) Division (B) of this section does not apply when a drug	37
is being purchased for use in administering the drug to an	38
individual who is receiving care in or through a hospital,	39
ambulatory surgical facility, nursing home, residential care	40
facility, freestanding rehabilitation facility, hospice care	41
program, home and community-based services provider, residential	42
facility for individuals with mental illness or developmental	43
disabilities, physician office, or any similar health care	44
facility, location, or provider.	45